STAT

Kamala Harris becomes the latest Democratic candidate to zero in on drug prices

Kamala Harris on Tuesday became the second Democratic candidate in as many days to unveil a detailed plan to lower drug prices, following a similar announcement from Joe Biden yesterday.
Sen. Kamala Harris (D-Calif.)

WASHINGTON — Sen. Kamala Harris (D-Calif.) on Tuesday became the second leading Democratic primary candidate in as many days to unveil a comprehensive plan to lower drug prices.

Harris’s plan relies on government price-setting, allowing the federal government to cap price levels for drugs

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About GLP-1 Spending, Biosimilar Patient Costs, And More
Spending on GLP-1 drugs like Ozempic and Wegovy ballooned last year and they're set to cost the U.S. health care system and the federal government still more.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks